Emmaus Life Sciences, Inc. EMMA
EMMA
Emmaus Life Sciences, Inc. NSPDF
Naturally Splendid Enterprises Ltd. PSYBF
PsyBio Therapeutics Corp. ENZC
Enzolytics Inc. UNBX
Unity Biotechnology, Inc. DOSEF
Doseology Sciences Inc. IPIX
Innovation Pharmaceuticals Inc. SQZB
SQZ Biotechnologies Company HALB
Halberd Corporation GENPF
Genix Pharmaceuticals Corporation
Emmaus Life Sciences, Inc. NSPDF
Naturally Splendid Enterprises Ltd. PSYBF
PsyBio Therapeutics Corp. ENZC
Enzolytics Inc. UNBX
Unity Biotechnology, Inc. DOSEF
Doseology Sciences Inc. IPIX
Innovation Pharmaceuticals Inc. SQZB
SQZ Biotechnologies Company HALB
Halberd Corporation GENPF
Genix Pharmaceuticals Corporation
Performance
| Periode | EMMA | NSPDF | PSYBF | ENZC | UNBX | DOSEF | IPIX | SQZB | HALB | GENPF |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -25.00 % | 0.00 % | 0.00 % | -57.14 % | -94.22 % | 952.63 % | 2 150.00 % | 7.14 % | -12.50 % | -65.50 % |
| YTD | 41.18 % | 0.00 % | 0.00 % | -68.42 % | -95.08 % | 611.74 % | 4 400.00 % | 0.00 % | -46.15 % | -65.50 % |
| 1Y | -30.64 % | 0.00 % | -98.00 % | -82.35 % | -95.93 % | 523.05 % | 542.86 % | 30.43 % | -53.33 % | -65.50 % |
| 3Y | -92.94 % | 823.08 % | -99.85 % | -99.41 % | -98.65 % | 400.00 % | -86.36 % | -98.85 % | -79.21 % | -74.73 % |
| 5Y | -98.63 % | 1 179.32 % | -99.97 % | -97.12 % | -99.86 % | 42.86 % | -97.84 % | -99.77 % | -96.01 % | -90.61 % |
| 10Y | -99.98 % | 240.91 % | -99.97 % | -99.39 % | -99.97 % | 42.86 % | -99.67 % | -99.77 % | 950.00 % | -90.61 % |
| Depuis le début | -98.00 % | 143.90 % | -99.97 % | -100.00 % | -99.97 % | 42.86 % | -96.25 % | -99.77 % | -97.90 % | -90.61 % |